ASTERLUNA CONTINU 100 micrograms/20 micrograms, film-coated tablet 84 tablets
Active ingredients: Levonorgestrel, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet84 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ASTERLUNA CONTINU 100 microgrammes/20 microgrammes, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 3 plaquettes PVC PVDC aluminium de 28 comprimés (21 comprimés roses et de 7 comprimés blancs)
- Marketing authorisation holder
- EXELTIS HEALTHCARE (ESPAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61273686CIP73014915CIP133400930149157Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVONORGESTRELcomprimé actif rose | 0,1 mg · un comprimé | SA |
| ÉTHINYLESTRADIOLcomprimé actif rose | 0,02 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.